Search Results - "ARENDASH, G. W"

Refine Results
  1. 1

    Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production by Arendash, G.W., Schleif, W., Rezai-Zadeh, K., Jackson, E.K., Zacharia, L.C., Cracchiolo, J.R., Shippy, D., Tan, J.

    Published in Neuroscience (03-11-2006)
    “…A recent epidemiological study suggested that higher caffeine intake over decades reduces the risk of Alzheimer’s disease (AD). The present study sought to…”
    Get full text
    Journal Article
  2. 2

    Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice by Sanchez-Ramos, J, Song, S, Sava, V, Catlow, B, Lin, X, Mori, T, Cao, C, Arendash, G.W

    Published in Neuroscience (29-09-2009)
    “…Abstract Granulocyte colony stimulating factor (G-CSF) is a multi-modal hematopoietic growth factor, which also has profound effects on the diseased CNS. G-CSF…”
    Get full text
    Journal Article
  3. 3

    Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit? by Dragicevic, N, Bradshaw, P.C, Mamcarz, M, Lin, X, Wang, L, Cao, C, Arendash, G.W

    Published in Neuroscience (30-06-2011)
    “…Abstract We have recently reported that long-term exposure to high frequency electromagnetic field (EMF) treatment not only prevents or reverses cognitive…”
    Get full text
    Journal Article
  4. 4

    Evidence That Oxidative Stress Is Associated with the Pathophysiology of Inherited Hydrocephalus in the H-Tx Rat Model by Socci, D.J., Bjugstad, K.B., Jones, H.C., Pattisapu, J.V., Arendash, G.W.

    Published in Experimental neurology (01-01-1999)
    “…Oxidative stress can contribute to many neurological disease processes. Because many events known to involve oxidative stress (infection, hemorrhage, brain…”
    Get full text
    Journal Article
  5. 5

    Lifelong immunization with human β-amyloid (1–42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging by Jensen, M.T., Mottin, M.D., Cracchiolo, J.R., Leighty, R.E., Arendash, G.W.

    Published in Neuroscience (2005)
    “…Although both active and passive β-amyloid (Aβ) immunotherapy have been shown to protect against or lessen cognitive impairment in various Alzheimer's…”
    Get full text
    Journal Article
  6. 6

    The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimerʼs transgenic mice by Garcia, M. F, Gordon, M. N, Hutton, M, Lewis, J, McGowan, E, Dickey, C. A, Morgan, D, Arendash, G. W

    Published in Neuroreport (19-01-2004)
    “…To determine the effects of the recessive retinal degeneration (rd) gene on behavioral performance, three Alzheimerʼs transgenic lines (APPsw, P30lL,…”
    Get full text
    Journal Article
  7. 7

    Short-Term β-Amyloid Vaccinations Do Not Improve Cognitive Performance in Cognitively Impaired APP+PS1 Mice by Austin, L, Arendash, G. W, Gordon, M. N, Diamond, D. M, DiCarlo, G, Dickey, C, Ugen, K, Morgan, D

    Published in Behavioral neuroscience (01-06-2003)
    “…Prior work demonstrated that β-amyloid (Aβ) immunotherapy for 8 months prevented cognitive impairment in 16-month-old APP+PS1 transgenic mice. In the present…”
    Get full text
    Journal Article
  8. 8

    Chronic antioxidant treatment improves the cognitive performance of aged rats by Socci, D.J., Crandall, B.M., Arendash, G.W.

    Published in Brain research (25-09-1995)
    “…Free radicals and oxidative damage have been implicated in brain aging and several neurodegenerative diseases. The purpose of the present study was to…”
    Get full text
    Journal Article
  9. 9

    Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study by Oestreicher, E, Sengstock, G J, Riederer, P, Olanow, C W, Dunn, A J, Arendash, G W

    Published in Brain research (10-10-1994)
    “…Parkinson's-diseased (PD) brains have increased levels of iron in the zona compacta of the substantia nigra (SNc). To determine whether these elevated nigral…”
    Get more information
    Journal Article
  10. 10

    Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21 by Arendash, Gary W., Sengstock, Gregory J., Sanberg, Paul R., Kem, William R.

    Published in Brain research (20-03-1995)
    “…The ability of two synthetic nicotine receptor ligands, GTS-21 and DMAB, to chronically enhance the cognitive function of aged rats was evaluated in three…”
    Get full text
    Journal Article
  11. 11

    Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice by Echeverria, V, Burgess, S, Gamble-George, J, Zeitlin, R, Lin, X, Cao, C, Arendash, G.W

    Published in Neuroscience (15-09-2009)
    “…Abstract Alzheimer's disease (AD) is characterized by memory loss and the upregulation of pro-neuroinflammatory factors such as cRaf-1, cyclooxygenase-2…”
    Get full text
    Journal Article
  12. 12

    In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson’s and Alzheimer’s diseases by Linert, W., Bridge, M.H., Huber, M., Bjugstad, K.B., Grossman, S., Arendash, G.W.

    Published in Biochimica et biophysica acta (07-07-1999)
    “…An inverse relationship appears to exist between cigarette smoking and the risk of Parkinson’s and Alzheimer’s diseases. Since both diseases are characterized…”
    Get full text
    Journal Article
  13. 13

    A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice by Arendash, G.W, Jensen, M.T, Salem, N, Hussein, N, Cracchiolo, J, Dickson, A, Leighty, R, Potter, H

    Published in Neuroscience (26-10-2007)
    “…Abstract Although a number of epidemiologic studies reported that higher intake of omega-3 fatty acids (largely associated with fish consumption) is protective…”
    Get full text
    Journal Article
  14. 14

    Metals and free radicals in neurodegeneration by Olanow, C W, Arendash, G W

    Published in Current opinion in neurology (01-12-1994)
    “…Substantial evidence has accumulated implicating metals and free radicals in the pathogenesis of the major neurodegenerative disorders (Parkinson's disease,…”
    Get more information
    Journal Article
  15. 15

    Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex by Sastry, S., Arendash, G.W.

    Published in Neuroscience (01-08-1995)
    “…The substantia nigra and globus pallidus (two iron-rich brain areas) receive a substantial innervation from the neostriatum, a considerable amount of which is…”
    Get full text
    Journal Article
  16. 16

    Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers by Sengstock, G J, Olanow, C W, Menzies, R A, Dunn, A J, Arendash, G W

    Published in Journal of neuroscience research (01-05-1993)
    “…Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the…”
    Get more information
    Journal Article
  17. 17

    Nicotine enhances morris water maze performance of young and aged rats by Socci, Debra J., Sanberg, Paul R., Arendash, Gary W.

    Published in Neurobiology of aging (01-09-1995)
    “…We have recently demonstrated that nicotine administration improves the acquisition and/or memory retention of aged rats in 17-arm radial maze, Lashley III…”
    Get full text
    Journal Article
  18. 18

    Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease by Morgan, Dave, Diamond, David M, Gottschall, Paul E, Ugen, Kenneth E, Dickey, Chad, Hardy, John, Duff, Karen, Jantzen, Paul, DiCarlo, Giovanni, Wilcock, Donna, Connor, Karen, Hatcher, Jaime, Hope, Caroline, Gordon, Marcia, Arendash, Gary W

    Published in Nature (London) (21-12-2000)
    “…Vaccinations with amyloid-β peptide (AB) can dramatically reduce amyloid deposition in a transgenic mouse model of Alzheimer's disease. To determine if the…”
    Get full text
    Journal Article
  19. 19

    Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage by Su, George C, Arendash, Gary W, Kalaria, Rajesh N, Bjugstad, Kimberly B, Mullan, Michael

    Published in Brain research (06-02-1999)
    “…Vascular wall levels of soluble β-amyloid 1–40 (Aβ 1–40) are elevated in Alzheimer's disease (AD). Moreover, plasma Aβ levels are increased in familial AD, as…”
    Get full text
    Journal Article
  20. 20

    Nicotine enhances the learning and memory of aged rats by Aren, Gary W., Sanberg, Paul R., Sengstock, Gregory J.

    Published in Pharmacology, biochemistry and behavior (01-11-1995)
    “…The cognitive performance of young adult (2–3-month-old) and aged (22–24 month-old) rats was characterized in one of three different behavioral tasks, and the…”
    Get full text
    Journal Article